Dr. Marty Tenenbaum, Chairman and co-Founder of CollabRx recently spoke at the Open Science Summit 2011 about Open Medicine and Clinical Trials 2.0. Dr. Tenenbaum described the concept of an open community that compiles and continually refines information about cancer subtypes and treatments based on actual patient outcomes.
The Targeted Therapy Finder helps melanoma patients and their physicians identify novel treatments that target the molecular processes driving their tumors. Users are guided through a three step process: 1. Identify the relevant genetic tests to run on a tumor or biopsy specimen 2. Based on test results and other information, identify the tumor’s subtype 3. Find the best available treatments (drugs & clinical trials). continue reading »
CollabRx founder and CEO Marty Tenenbaum, is featured in this short video describing how CollabRx helped the parents of Addi and Cassi Hempel organize research to fight Niemann-Pick C, a devastating disease sometimes called “childhood Alzheimer’s”.